Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selexipag effects on right ventricular strain-area loop in pulmonary arterial hypertension
NL-OMON46728Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of selexipag in pulmonary arterial hypertension (PAH), sponsored by Radboud University Medical Center. Primary endpoint: Slope systolic deformation. Started Sep 2018; status: active, not recruiting.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NL-OMON46728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46728.